On August 6, 2026, the first lockup expiration in SpaceX's post-IPO schedule freed up to roughly 911.5 million shares held by company insiders, allowing some investors to sell for the first time since the company's public debut Investopedia. The expiration could roughly triple the tradable public float in SPCX shares Reuters. By value, approximately $123 billion in stock became eligible to trade Investing.com.

A lockup is a contractual restriction that prevents insiders — executives, employees, and early backers — from selling their shares for a set period after an IPO. The goal is to keep a flood of insider selling from overwhelming the market right after a company goes public.

SpaceX closed its initial public offering on June 15, 2026, raising gross proceeds of approximately $85 billion SpaceX IR. The IPO comprised 638,888,888 shares of Class A common stock in aggregate, with 555,555,555 shares offered at a public offering price of $135.00 per share. An additional 55,555,555 shares were registered under a separate EU prospectus at a maximum price of $162.00 per share. Shares trade on the Nasdaq Global Select Market under ticker SPCX SpaceX Q2 2026 Results.

The lockup release was not unconditional. SpaceX's stock was required to hold $175.50 or higher for five of ten consecutive trading days as part of the lockup terms — a price threshold mechanism designed to prevent insiders from selling into a declining market Investing.com. That condition was met, clearing the way for the August 6 release.

The staggered lockup schedule means today's expiration is the first of several. Additional tranches will free more shares through December 2026, raising the tradable float to 40% of total shares outstanding by year-end Reuters. By mid-2027, the schedule will have unlocked an additional 12.9 billion shares Reuters. The remaining 60% of shares, including Elon Musk's stake, will stay locked until that mid-2027 window Reuters. Musk himself is restricted from selling until 366 days after the IPO date Reuters.

The "float" refers to the number of shares available for public trading. When the float triples overnight, the market suddenly has far more shares to absorb. In this case, the selling pressure comes not from ordinary investors rebalancing their portfolios but from insiders whose cost basis — what they originally paid — is a fraction of the $135 IPO price and who have been unable to sell until now. The price-gate condition, requiring SPCX to hold above $175.50 for five of ten sessions, gave a green light only after the stock showed enough buyer interest to support that level. Whether that demand holds up under several hundred million newly tradable shares is the open question.

Reuters reported that SPCX shares slipped on the lockup expiry day, adding to what the outlet characterized as post-IPO woes for the stock Reuters. No specific percentage decline or closing price was provided in the available reporting.

The staggered structure is the more consequential design choice. Rather than releasing all restricted shares in a single cliff expiration, SpaceX and its underwriters opted for a phased release that extends through mid-2027. This converts what would have been a one-day supply shock into a persistent overhang — a lingering ceiling on the stock that doesn't reflect the company's actual performance but rather the constant drip of new shares entering the market. For institutional investors running position models, the stock's effective float is a moving target. Each tranche expiry introduces a step-up in available shares that demands repricing of liquidity premiums (the discount buyers demand for less easily traded stocks), bid-ask depth assumptions, and portfolio weight ceilings. Models that treat lockup expiry as a one-time event will systematically misprice that drag.

The 12.9 billion shares set to unlock by mid-2027 dwarfs the 911.5 million freed today. That figure is orders of magnitude larger than the IPO's 638.9 million Class A share offering, which means the vast majority of SpaceX's equity was retained by insiders, founders, and early investors rather than sold to the public. The slow-release structure means this supply will bleed into the market over roughly twelve months rather than cascading in a single session. Investors evaluating SPCX now face not just today's float expansion but a calendar of incremental supply events stretching well into 2027, each requiring its own test of whether buyers can absorb the new shares.